Brolucizumab for Choroidal Neovascular Membrane with Pigment Epithelial Tear and Subretinal Fluid

The aim of this study was to determine the utility of brolucizumab in the management of choroidal neovessels (CNV) with a retinal pigment epithelial (RPE) tear and subretinal fluid. We used a case series of patients with CNV who developed an RPE tear either spontaneously or following an intravitreal...

Descripción completa

Detalles Bibliográficos
Autores principales: Bilgic, Alper, Kodjikian, Laurent, Vasavada, Shail, Jha, Shyamal, Srivastava, Samaresh, Sudhalkar, Aditya, Mathis, Thibaud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197900/
https://www.ncbi.nlm.nih.gov/pubmed/34070774
http://dx.doi.org/10.3390/jcm10112425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197900/
https://www.ncbi.nlm.nih.gov/pubmed/34070774
http://dx.doi.org/10.3390/jcm10112425

Ejemplares similares